Login
Home
Charts
Search
Watchlist
Products

ZR2 Bioenergy Ltd

ZR2·BSE
142.50-0.70%Tue, 22 Sept '26

ZR2 Bioenergy Ltd

ZR2
BSE
142.50
-0.70%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
227Cr
Close
Close Price
142.50
Industry
Industry
Trading
PE
Price To Earnings
55.23
PS
Price To Sales
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2021Dec 2021Jun 2022Sep 2022Dec 2022Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
Other Income
Other IncomeCr
000000001000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
0.0188.581.8-29.0
NPM
NPM%
EPS
EPS
0.0-0.2-0.30.0-0.2-0.70.30.90.80.60.60.6
QuarterSep 2021Dec 2021Jun 2022Sep 2022Dec 2022Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
Other Income
Other IncomeCr
000000001000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
0.0188.581.8-29.0
NPM
NPM%
EPS
EPS
0.0-0.2-0.30.0-0.2-0.70.30.90.80.60.60.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2025Mar 2026TTM
Revenue
RevenueCr
1100
Growth
Revenue Growth%
-100.0
Expenses
ExpensesCr
1211
Operating Profit
Operating ProfitCr
00-1-1
OPM
OPM%
4.3-26.6
Other Income
Other IncomeCr
0122
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0000
PBT
PBTCr
0011
Tax
TaxCr
0000
PAT
PATCr
0011
Growth
PAT Growth%
1,008.6
NPM
NPM%
33.66.0
EPS
EPS
0.20.32.82.6
Financial YearMar 2022Mar 2025Mar 2026TTM
Revenue
RevenueCr
1100
Growth
Revenue Growth%
-100.0
Expenses
ExpensesCr
1211
Operating Profit
Operating ProfitCr
00-1-1
OPM
OPM%
4.3-26.6
Other Income
Other IncomeCr
0122
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0000
PBT
PBTCr
0011
Tax
TaxCr
0000
PAT
PATCr
0011
Growth
PAT Growth%
1,008.6
NPM
NPM%
33.66.0
EPS
EPS
0.20.32.82.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
00
Reserves
ReservesCr
17140
Current Liabilities
Current LiabilitiesCr
01
Non Current Liabilities
Non Current LiabilitiesCr
00
Total Liabilities
Total LiabilitiesCr
140141
Current Assets
Current AssetsCr
2021
Non Current Assets
Non Current AssetsCr
120121
Total Assets
Total AssetsCr
140141
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
00
Reserves
ReservesCr
17140
Current Liabilities
Current LiabilitiesCr
01
Non Current Liabilities
Non Current LiabilitiesCr
00
Total Liabilities
Total LiabilitiesCr
140141
Current Assets
Current AssetsCr
2021
Non Current Assets
Non Current AssetsCr
120121
Total Assets
Total AssetsCr
140141

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
131-1
Investing Cash Flow
Investing Cash FlowCr
0-1170
Financing Cash Flow
Financing Cash FlowCr
01000
Net Cash Flow
Net Cash FlowCr
1150
Free Cash Flow
Free Cash FlowCr
-88
CFO To PAT
CFO To PAT%
233.334,421.7-69.0
CFO To EBITDA
CFO To EBITDA%
1,820.0-7,816.8101.5
Financial YearMar 2022Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
131-1
Investing Cash Flow
Investing Cash FlowCr
0-1170
Financing Cash Flow
Financing Cash FlowCr
01000
Net Cash Flow
Net Cash FlowCr
1150
Free Cash Flow
Free Cash FlowCr
-88
CFO To PAT
CFO To PAT%
233.334,421.7-69.0
CFO To EBITDA
CFO To EBITDA%
1,820.0-7,816.8101.5

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7100157227
Price To Earnings
Price To Earnings
18.41,120.0156.755.2
Price To Sales
Price To Sales
6.267.1
Price To Book
Price To Book
1.65.91.11.6
EV To EBITDA
EV To EBITDA
-203.5-202.8-295.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.3
OPM
OPM%
4.3-26.6
NPM
NPM%
33.66.0
ROCE
ROCE%
1.20.70.7
ROE
ROE%
0.50.70.7
ROA
ROA%
0.10.70.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7100157227
Price To Earnings
Price To Earnings
18.41,120.0156.755.2
Price To Sales
Price To Sales
6.267.1
Price To Book
Price To Book
1.65.91.11.6
EV To EBITDA
EV To EBITDA
-203.5-202.8-295.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.3
OPM
OPM%
4.3-26.6
NPM
NPM%
33.66.0
ROCE
ROCE%
1.20.70.7
ROE
ROE%
0.50.70.7
ROA
ROA%
0.10.70.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
ZR2 Bioenergy is a biofuel manufacturer in the middle of a complete reinvention. After a takeover in mid-2024, the former chemical trader has staked its future on a single, large-scale biorefinery that will turn sugarcane into ethanol, gas, and eventually green hydrogen - all on one site, with no middlemen. Its recurring approach is to secure a long-term operating lock on an existing industrial asset, fund the build-out entirely with equity rather than debt, and sell every output into government-backed offtake programmes. # Business segments A single integrated biorefinery at the pre-revenue stage, structured as one operating engine with three planned phases - ethanol and biogas first, then zero-liquid-discharge expansion, then solar and green hydrogen - plus two early-stage subsidiaries that will eventually feed power and hydrogen back into the same site. ## 1. Cane-based biorefinery: the group’s founding production engine **The company has secured a 29-year operating lock on an existing distillery and biogas plant co-located with Asia’s largest cooperative sugar factory, giving it assured feedstock at the factory gate and a ready workforce from day one.** - **Built on someone else’s sugar** - the entire facility sits inside the premises of Padmashri Dr. Vithal Rao Vikhe Patil Sahakari Sakhar Karkhana Ltd (Pravara Sugar Factory) in Maharashtra under a BOOT (Build-Own-Operate-Transfer) agreement that runs for 15 years, extendable by another 14. That means the company does not need to grow or buy cane on the open market; the sugar factory’s own cane supply becomes the biorefinery’s feedstock, eliminating the single largest cost and supply risk for a biofuel plant. - **Acquired, not built from scratch** - the deal includes a fully operational distillery, an ethanol and extra-neutral-alcohol (ENA) plant, a raw biogas plant, a multi-effect evaporator (MEE), a reverse-osmosis (RO) unit, and the skilled workers who already run them. The company gets immediate production capability rather than facing a multi-year greenfield construction delay, with in-principle approval from the Maharashtra government already in hand and final BOOT execution expected by June 2025. - **Every output has a buyer lined up** - ethanol and industrial ethanol will be sold to government Oil Marketing Companies (OMCs) under India’s Ethanol Blending Programme, which mandates mixing ethanol into petrol and has already pushed national blending rates close to 19%. Compressed biogas (CBG) qualifies for the SATAT scheme, a government programme that guarantees offtake, while bio-potash powder - a fertiliser by-product recovered from the evaporator - creates an extra revenue stream from what would otherwise be waste. - **A three-phase build-out with the permits already secured** - Phase I simply stabilises the existing plant. Phase II adds expanded ethanol capacity, a zero-liquid-discharge system (meaning no wastewater leaves the site), bio-potash recovery, and a waste-to-energy cogeneration unit that will make the plant self-sufficient in power. Phase III brings in a solar plant and a green hydrogen unit linked to a BPCL pipeline, with environmental clearance already granted for Phase II assets and no further extension needed for the solar plant, hydrogen plant, and other listed units - no further regulatory delay. - **Paid for with equity, not bank debt** - the entire Phase I was financed through compulsory convertible debentures and warrants issued to the promoter group and partners, with no external borrowings on the balance sheet. That clean capital structure means the company is not servicing interest during the commissioning period, and the promoter has committed to further equity infusions if needed. ## 2. Solar subsidiary: captive power for the biorefinery **A wholly owned subsidiary was created to build the solar plant that will eventually power the main biorefinery, with a strategic stake sale already executed to bring the hydrogen subsidiary in as a partner.** - **Purpose-built for self-supply** - ZR2 Solar Private Limited was incorporated in October 2024 to generate and supply renewable power, primarily for the parent company’s own consumption at the biorefinery site, with any surplus sold to the grid or industrial customers. It is the Phase III power solution, not a standalone merchant power business. - **Ownership restructured before operations began** - in March 2025, the board approved diluting its stake in the solar subsidiary from 100% to 51%, so that the two future energy units share a common ownership structure from the start. The subsidiary had barely begun operations at that point, with turnover of just ₹2 lakh in its first months. # Group structure and partners **The company is controlled by a UAE-based investment holding company that took a 61% stake in mid-2024 and has since consolidated its holding above 90% through debt conversion, while the biorefinery partner is also a shareholder.** - **Promoter is an Abu Dhabi vehicle** - ZR2 Group Holdings Ltd, incorporated in the Abu Dhabi Global Market in April 2023, acquired 60.96% of the company from six selling promoters in May 2024 at ₹65 per share, followed by a mandatory open offer that took its holding to 61%. The two individuals behind it are Jimmy Olsson (75%) and Nilesh Jain (25%), with Olsson serving as Chairman and Managing Director of the Indian listed entity. - **Debt conversion pushed the stake to 91%** - when the compulsory convertible debentures issued to fund Phase I were converted into equity in February 2026, the promoter’s shareholding jumped to 91.26%, while the warrants issued alongside them lapsed unexercised and the 25% deposit - roughly ₹42 crore - was forfeited. - **The sugar factory is both landlord and investor** - Padmashri Dr. Vithal Rao Vikhe Patil Sahakari Sakhar Karkhana Ltd, the cooperative that hosts the biorefinery, subscribed to 92,05,000 warrants in the 2024 fundraise, aligning its interests with the company’s success. - **Offtake and infrastructure partners are state-backed** - ethanol and CBG sales will flow through OMCs and government agencies under long-term agreements, while the planned hydrogen output will connect to a BPCL pipeline and a City Gas Distribution network just 1.5 kilometres from the plant gate.

Documents — ZR2 Bioenergy Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/vus2ttarh4ujs1i43e635qq3.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/tbum8cuqaoja49yozh0cz39l.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/krjebxaac995e3lz8i3igqsg.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/5mdv0bv9316ri8jy2xl6gi1o.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/ufjcjqjj8sv3zn3sd2j5zsx8.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/vcb19wiuzdqz0s6hds7eudsi.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/9kf41yzmbdu0fmv7aubg3pte.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/pa1vh8tsuyhhb1umks32ifqr.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/miqqzoaken5lkhguyos51lye.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/qwvqn1o3bel443ijkhmg1avc.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/paagtckewyw5aydsb5g0p8w9.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/ern9aqh0ms3nao8fbbsv7zqt.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/nbr62uo2d98w9doa2q553ntq.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/luu0b5j6v3r5oo36occkzg6j.pdf